The Peterson-KFF Health System Tracker provides clear, up-to-date information on trends, drivers and issues that impact the performance of the system. It also illustrates how the U.S. is performing relative to other countries and how different parts of the system are performing relative to one another. A partnership of the Peterson Center on Healthcare and the KFF, the Tracker’s work goal places a heavy emphasis on data and evidence, addressing key questions through collections of charts, which provide data with additional context and synthesis of the latest research and developments. The Tracker also provide regular insight briefs for a more in-depth look at topical questions.
Featured Peterson-KFF Resources
This analysis uses government data to examine the burden of medical debt, including variations based on age, race and ethnicity, and health status . It estimates 9% of adults – or roughly 23 million people -owe medical debt, including 11 million who owe more than $2,000.
Issue Brief See More
Related Peterson-KFF Resources
- COVID-19 preventable mortality
- Many households do not have enough money to pay cost-sharing typical in private health plans
- Unvaccinated COVID patients cost the U.S. health system billions of dollars
- Most private insurers are no longer waiving cost-sharing for COVID-19 treatment
- Few Adults Are Aware of Hospital Price Transparency Requirements
- Surprise Bills Vary by Diagnosis and Type of Admission
- Overall inflation has not yet flowed through to the health sector
- How does the quality of the U.S. health care system compare to other countries?
- Health System Dashboard
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician and clinic care, and prescription drugs.
Interactive See More
- view as grid
- view as list
Visualizing Health Policy: The Costs and Outcomes of Mental Health and Substance Use Disorders in the US
This Visualizing Health Policy infographic looks at costs and outcomes of mental health and substance use disorders in the United States (US).Infographic Read More
New Analysis Finds Inpatient Coronavirus Treatment Costs Could Top $20K for Patients with Employer Coverage
A new issue brief estimates potential coronavirus treatment costs to large employer health plans and their enrollees by looking at typical spending for hospital admissions for pneumonia. The analysis finds that, for pneumonia admissions with major complications and comorbidities, the average total cost is $20,292. In comparison, the average cost…News Release Read More
This Visualizing Health Policy infographic looks at the experience of unexpected or “surprise” medical bills in the United States. Out-of-network charges typically expose individuals to higher cost-sharing when they use services, and may lead to balance billing – in which providers bill patients directly, and often unexpectedly, at a higher…News Release Read More
A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief also includes new analysis of geographic variation in health prices.Issue Brief Read More
Private insurance plans have taken a variety of steps to expand telemedicine uptake and access during the COVID-19 pandemic. A new issue brief on the Peterson-KFF Health System Tracker examines four actions private insurers have taken to promote telehealth usage among plan enrollees.Issue Brief Read More
Telemedicine has been seen as a way to possibly improve access to care while also lowering costs. New analysis available on the Peterson-Kaiser Health System Tracker finds that the share of large employers offering health plans that cover telemedicine has increased significantly over the last three years.Issue Brief Read More
Analysis: Many Private Insurers Offer Financial Relief for COVID-19 Treatment, but Cost-Sharing Waivers Are Expiring
A new analysis finds that most people with individual or fully-insured group market coverage are in plans that waived cost-sharing for COVID-19 treatment, though many of those waivers are set to expire in the coming months. About 88% – nearly nine in ten – enrollees in the individual and fully-insured…News Release Read More
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician and clinic care, and prescription drugs.Interactive Read More